Abstract
This study sought to assess whether intracoronary adenosine or nitroprusside following thrombus aspiration (TA) is superior to TA alone for the prevention of microvascular obstruction (MVO) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 580-589 |
| Numero di pagine | 10 |
| Rivista | JACC: Cardiovascular Interventions |
| Volume | 6 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- Adenosine
- Aged
- Coronary Angiography
- Coronary Circulation
- Drug Administration Schedule
- Electrocardiography
- Female
- Heart Failure
- Hospitalization
- Humans
- Italy
- Male
- Microcirculation
- Middle Aged
- Myocardial Infarction
- Nitroprusside
- Percutaneous Coronary Intervention
- Recurrence
- Suction
- Thrombectomy
- Time Factors
- Treatment Outcome
- Vasodilation
- Vasodilator Agents
Fingerprint
Entra nei temi di ricerca di 'Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver